BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gasser E, Braunwarth E, Riedmann M, Cardini B, Fadinger N, Presl J, Klieser E, Ellmerer P, Dupré A, Imai K, Malik H, Baba H, Ulmer H, Schneeberger S, Öfner D, Dinnewitzer A, Stättner S, Primavesi F. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score. PLoS One 2019;14:e0217411. [PMID: 31150437 DOI: 10.1371/journal.pone.0217411] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Beppu T, Yamamura K, Sakamoto K, Honda G, Kobayashi S, Endo I, Hasegawa K, Kotake K, Itabashi M, Hashiguchi Y, Kotera Y, Yamaguchi T, Natsume S, Tabuchi K, Kobayashi H, Yamaguchi K, Morita S, Kikuchi K, Miyazaki M, Sugihara K, Yamamoto M, Takahashi K, Joint Committee for Nationwide Survey on Colorectal Liver Metastasis. Validation study of the JSHBPS nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era ‐ a nationwide survey in Japan. J Hepato Biliary Pancreat 2022. [DOI: 10.1002/jhbp.1256] [Reference Citation Analysis]
2 Signorelli C, Amodio PM, Chilelli MG, Santoro R, Schirripa M, Ranalli TV, Pessina G, Giron Berrios JR, Natoni F, Virtuoso A, Primi F, Mazzotta M, Nelli F, Fabbri A, Marrucci E, Ruggeri EM. Real-Life Experience of the Prognostic Significance of the Primary Tumor Location on the Timing of Colorectal Liver Metastases: A Retrospective Analysis. Cureus 2022;14:e30607. [PMID: 36299600 DOI: 10.7759/cureus.30607] [Reference Citation Analysis]
3 Alexandrescu ST, Dinu IM, Diaconescu AS, Micu A, Pasare E, Durdu C, Dorobantu BM, Popescu I. Embryologic Origin of the Primary Tumor and RAS Status Predict Survival after Resection of Colorectal Liver Metastases. Medicina (Kaunas) 2022;58:1100. [PMID: 36013567 DOI: 10.3390/medicina58081100] [Reference Citation Analysis]
4 Di Martino M, Primavesi F, Syn N, Dorcaratto D, de la Hoz Rodríguez Á, Dupré A, Piardi T, Rhaiem R, Blanco Fernández G, de Armas Conde N, Rodríguez Sanjuán JC, Fernández Santiago R, Fernández-Moreno MC, Ferret G, López Ben S, Suárez Muñoz MÁ, Perez-Alonso AJ, Koh YX, Jones R, Martín-Pérez E. Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring. Ann Surg Oncol 2022. [PMID: 35849284 DOI: 10.1245/s10434-022-12027-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Valenzuela CD, Moaven O, Gawdi R, Stauffer JA, Del Piccolo NR, Cheung TT, Corvera CU, Wisneski AD, Cha C, Mangieri CW, Zarandi NP, Dourado J, Perry KC, Russell G, Shen P. Association of primary tumor laterality with surgical outcomes for colorectal liver metastases: results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC). HPB (Oxford) 2022:S1365-182X(22)00066-1. [PMID: 35289279 DOI: 10.1016/j.hpb.2022.02.006] [Reference Citation Analysis]
6 Line P, Adam R. Liver Transplantation. Colorectal Liver Metastasis 2022. [DOI: 10.1007/978-3-031-09323-4_26] [Reference Citation Analysis]
7 Kim N. Sex Difference of Colorectal Cancer. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_20] [Reference Citation Analysis]
8 Lijuan Y, Yinhang W, Yangyanqiu W, Xiaohui H, Yunhai W, Shuwen H. Differences in T cell immune-related lncRNA and mRNA expression patterns between right- and left-sided colorectal cancers. Hum Immunol 2021:S0198-8859(21)00207-X. [PMID: 34426030 DOI: 10.1016/j.humimm.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, de Vries JJJ, Versteeg KS, Lissenberg-Witte BI, van den Tol MP, Meijerink MR. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE). Biomedicines 2021;9:962. [PMID: 34440165 DOI: 10.3390/biomedicines9080962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
10 Zhao J, Zhu J, Huang C, Yuan R, Zhu Z. Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysis. Acta Chir Belg 2021;:1-16. [PMID: 34278951 DOI: 10.1080/00015458.2021.1956799] [Reference Citation Analysis]
11 Treska V, Skala M, Prochazkova K, Svejdova A, Petrakova T, Sebek J, Riha I, Rosendorf J, Polak R, Skalicky T, Liska V. Long-term Results of Surgery for Colorectal Liver Metastases in Terms of Primary Tumour Location and Clinical Risk Factors. In Vivo 2020;34:2675-85. [PMID: 32871799 DOI: 10.21873/invivo.12087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sasaki K, Gagnière J, Dupré A, Ardiles V, O'Connor JM, Wang J, Moro A, Morioka D, Buettner S, Gau L, Ribeiro M, Wagner D, Andreatos N, Løes IM, Fitschek F, Kaczirek K, Lønning PE, Kornprat P, Poultsides G, Kamphues C, Imai K, Baba H, Endo I, Kwon CHD, Aucejo FN, de Santibañes E, Kreis ME, Margonis GA. Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scores. J Hepatobiliary Pancreat Sci 2021;28:581-92. [PMID: 33797866 DOI: 10.1002/jhbp.963] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Abancens M, Bustos V, Harvey H, McBryan J, Harvey BJ. Sexual Dimorphism in Colon Cancer. Front Oncol 2020;10:607909. [PMID: 33363037 DOI: 10.3389/fonc.2020.607909] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
14 Garajova I, Balsano R, Tommasi C, Dalla Valle R, Pedrazzi G, Ravaioli M, Spallanzani A, Leonardi F, Santini C, Caputo F, Riefolo M, Giuffrida M, Gelsomino F. Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection. Acta Biomed 2020;92:e2021061. [PMID: 33682832 DOI: 10.23750/abm.v92i1.11050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Zimmitti G, Panettieri E, Ardito F, Mele C, Maria V, Rosso E, Nuzzo G, Giuliante F. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study. Eur J Surg Oncol 2021;47:834-41. [PMID: 33032866 DOI: 10.1016/j.ejso.2020.09.011] [Reference Citation Analysis]
16 Cheng J, Qiu M, Zhang Y, Hong N, Shen D, Zhou J, Wang Y. Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy. AJR Am J Roentgenol 2020;215:1377-83. [PMID: 32991216 DOI: 10.2214/AJR.19.22280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Petrowsky H, Linecker M, Raptis DA, Kuemmerli C, Fritsch R, Kirimker OE, Balci D, Ratti F, Aldrighetti L, Voskanyan S, Tomassini F, Troisi RI, Bednarsch J, Lurje G, Fard-aghaie M, Reese T, Oldhafer KJ, Ghamarnejad O, Mehrabi A, Abraham MET, Truant S, Pruvot F, Hoti E, Kambakamba P, Capobianco I, Nadalin S, Fernandes ESM, Kron P, Lodge P, Olthof PB, van Gulik T, Castro-benitez C, Adam R, Machado MA, Teutsch M, Li J, Scherer MN, Schlitt HJ, Ardiles V, de Santibañes E, Brusadin R, Lopez-lopez V, Robles-campos R, Malagó M, Hernandez-alejandro R, Clavien P. First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases. Annals of Surgery 2020;272:793-800. [DOI: 10.1097/sla.0000000000004330] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
18 Han Y, Chai F, Wei J, Yue Y, Cheng J, Gu D, Zhang Y, Tong T, Sheng W, Hong N, Ye Y, Wang Y, Tian J. Identification of Predominant Histopathological Growth Patterns of Colorectal Liver Metastasis by Multi-Habitat and Multi-Sequence Based Radiomics Analysis. Front Oncol 2020;10:1363. [PMID: 32923388 DOI: 10.3389/fonc.2020.01363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
19 Uchino T, Ouchi A, Komori K, Kinoshita T, Oshiro T, Sano T, Shimizu Y. The prognostic relevance of primary tumor sidedness to surgical treatment for recurrent colon cancer. Surg Today 2021;51:94-100. [PMID: 32596797 DOI: 10.1007/s00595-020-02060-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Okuno M, Hatano E, Toda R, Nishino H, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokuka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival. J Hepatobiliary Pancreat Sci 2020;27:496-509. [PMID: 32362018 DOI: 10.1002/jhbp.747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Bingham G, Shetye A, Suresh R, Mirnezami R. Impact of primary tumour location on colorectal liver metastases: A systematic review. World J Clin Oncol 2020; 11(5): 294-307 [PMID: 32728532 DOI: 10.5306/wjco.v11.i5.294] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]